Aastrom Biosciences Widens Stem Cell Trial and Teva Wins Right to Sell Generic Lamictal
home > blogdigger
City of Industry, CA --(www.FinancialNewsUSA.com)-- 02/18/2005 - Biotech industry news provided by Financial News USA (OTC: FNWU). Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced recently that it has expanded the U.S. Phase I/II clinical trial of its adult stem cell-based Tissue Repair Cells (TR
- link to Aastrom Biosciences Widens Stem Cell Trial and Teva Wins Right to Sell Generic Lamictal -
Last update: 05/26/2005